Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Current Deferred Revenue (2016 - 2025)

National Research (NRC) has disclosed Current Deferred Revenue for 16 consecutive years, with $16.2 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue rose 2.63% to $16.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.2 million through Dec 2025, up 2.63% year-over-year, with the annual reading at $16.2 million for FY2025, 2.63% up from the prior year.
  • Current Deferred Revenue hit $16.2 million in Q4 2025 for National Research, down from $17.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $17.8 million in Q3 2025 to a low of $14.5 million in Q2 2024.
  • Historically, Current Deferred Revenue has averaged $16.2 million across 5 years, with a median of $16.0 million in 2023.
  • Biggest five-year swings in Current Deferred Revenue: grew 10.45% in 2021 and later fell 11.71% in 2022.
  • Year by year, Current Deferred Revenue stood at $17.2 million in 2021, then fell by 11.71% to $15.2 million in 2022, then fell by 2.4% to $14.8 million in 2023, then rose by 6.42% to $15.8 million in 2024, then increased by 2.63% to $16.2 million in 2025.
  • Business Quant data shows Current Deferred Revenue for NRC at $16.2 million in Q4 2025, $17.8 million in Q3 2025, and $15.6 million in Q2 2025.